Food and Drug Adminsitration

Novavax Gets a Federal Grant for Developing Its Novel Flu Vaccine

The company has landed a lucrative flu-vaccine contract with the U.S. government. It's worth $97 million over the first three years, and it can be extended for an additional two years, for a total contract value of $179.1 million. The technology could prove to be a lifesaver.

FDA Considers Weight-Loss Implant for the Barely Obese

Allergan's Lap-Band, a device implanted in the stomach to limit the amount of food that can be ingested, is already on the market to help the very obese lose weight. But now the company hopes to win approval for less obese patients to use the band.